In total 389 users and 95 healthcare professionals responded. Some users had more than 30 years of experience, while others had only just begun self-catheterisation. Average age of participants was 55 years (varying from 9-89).
Countries included were Sweden, Norway, Denmark, UK, the Netherlands, France, Germany and Switzerland.
The three main reasons for catheterisation were SCI (para-/tetraplegia), MS and different prostate diagnosis. 17 % of the users had slightly reduced hand function and 5 % stated that their hand function was considerably reduced. 41 % used a wheelchair and 97 % of the users catheterized themselves.
The three major advantages with LoFric Origo were:
LoFric® is the registered trademark of Wellspect HealthCare.
Building 3, The Heights
Tel: +44 (0)1932 838347
Fax: +44 (0)1932 854058
UK & Eire General enquiries email: firstname.lastname@example.org
Contact headquarters or a
subsidiary/distributor in another country.
©2019 Wellspect HealthCare, a Dentsply Sirona Company. All rights reserved.